Simulations Plus (NASDAQ:SLP) Releases FY 2025 Earnings Guidance

Simulations Plus (NASDAQ:SLP) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 1.070-1.200 for the period, compared to the consensus EPS estimate of 0.900. The company issued revenue guidance of $90.0 million-$93.0 million, compared to the consensus revenue estimate of $90.7 million. Simulations Plus also updated its FY25 guidance to $1.07-$1.20 EPS.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. StockNews.com lowered shares of Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. KeyCorp lowered their target price on shares of Simulations Plus from $40.00 to $35.00 and set an “overweight” rating for the company in a report on Wednesday. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research report on Wednesday. BTIG Research reduced their price objective on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, October 24th. Finally, Stephens began coverage on Simulations Plus in a research note on Friday, November 15th. They issued an “overweight” rating and a $39.00 target price on the stock. One investment analyst has rated the stock with a sell rating, one has given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $49.00.

Simulations Plus Stock Performance

Simulations Plus stock opened at $28.21 on Thursday. The stock has a market cap of $566.60 million, a PE ratio of 57.57 and a beta of 0.80. The stock has a fifty day moving average of $29.79 and a 200 day moving average of $34.00. Simulations Plus has a one year low of $24.00 and a one year high of $51.22.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The company had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. During the same period in the previous year, the business posted $0.18 earnings per share. The firm’s quarterly revenue was up 19.9% compared to the same quarter last year. As a group, sell-side analysts predict that Simulations Plus will post 1.1 EPS for the current fiscal year.

Insider Activity at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Friday, November 1st. The stock was sold at an average price of $27.66, for a total value of $553,200.00. Following the completion of the transaction, the director now owns 3,462,584 shares in the company, valued at approximately $95,775,073.44. The trade was a 0.57 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 19.40% of the stock is owned by corporate insiders.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.